Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance

Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer death in the United States. Pancreatic tumors are minimally infiltrated by T cells and are largely refractory to immunotherapy. Accordingly, the role of T-cell immunity in pancreatic cancer has been somewhat overlooked. Her...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Immunol Res
Asıl Yazarlar: Ajina, Reham, Malchiodi, Zoe X., Fitzgerald, Allison A., Zuo, Annie, Wang, Shangzi, Moussa, Maha, Cooper, Connor J., Shen, Yue, Johnson, Quentin R., Parks, Jerry M., Smith, Jeremy C., Catalfamo, Marta, Fertig, Elana J., Jablonski, Sandra A., Weiner, Louis M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8283778/
https://ncbi.nlm.nih.gov/pubmed/33509790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-20-0272
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller